Graig Suvannavejh
Stock Analyst at Mizuho Securities
(4.92)
# 220
Out of 4,712 analysts
870
Total ratings
54.1%
Success rate
26.4%
Average return
Main Sectors:
Stocks Rated by Graig Suvannavejh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRBP Corbus Pharmaceuticals Holdings | Reiterated: Buy | $33 | $10.60 | +211.47% | 26 | Sep 9, 2026 | |
| BLTE Belite Bio | Maintained: Buy | $220 → $234 | $192.85 | +21.34% | 13 | Sep 9, 2026 | |
| IDYA IDEAYA Biosciences | Maintained: Buy | $50 | $38.84 | +28.73% | 29 | Sep 1, 2026 | |
| PVLA Palvella Therapeutics | Reiterated: Buy | $240 | $152.28 | +57.60% | 9 | Aug 31, 2026 | |
| INSM Insmed | Reiterated: Buy | $192 → $195 | $124.89 | +56.14% | 57 | Aug 24, 2026 | |
| IMTX Immatics | Reiterated: Buy | $25 | $9.44 | +164.83% | 25 | Aug 20, 2026 | |
| LONA LeonaBio | Rated: Buy | $16 → $15 | $8.02 | +87.03% | 44 | Aug 19, 2026 | |
| AMLX Amylyx Pharmaceuticals | Reiterated: Buy | $24 → $42 | $33.88 | +23.97% | 46 | Aug 19, 2026 | |
| EYPT EyePoint | Maintained: Buy | $39 | $4.56 | +755.26% | 46 | Aug 17, 2026 | |
| NMRA Neumora Therapeutics | Reiterated: Buy | $4 | $1.25 | +220.00% | 26 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $306 → $316 | $207.82 | +52.05% | 158 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $13.25 | +13.21% | 8 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $13.93 | +115.36% | 23 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $4.03 | +98.51% | 2 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $87.22 | +14.65% | 15 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $13 | $8.08 | +60.89% | 36 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $35 | $35.36 | -1.02% | 32 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $4.78 | +151.05% | 40 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $51 | $42.07 | +21.23% | 82 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.5 | $2.47 | -39.27% | 39 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $5 | $16.28 | -69.29% | 7 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $1,500 → $75 | $0.5379 | +13,843.11% | 3 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.026 | n/a | 12 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 | $0.82 | n/a | 11 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €296.00 → €400.00 | €861.40 | n/a | 5 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | kr 2,270 → kr 2,754 | kr 2,170 | n/a | 3 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 26.50 → CHF 17.00 | CHF 5.08 | n/a | 2 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €16.50 | €23.15 | n/a | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 → $50 | $108.31 | n/a | 4 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $13 → $6.5 | $2.11 | n/a | 2 | Nov 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €14.00 → €6.00 | €2.31 | n/a | 2 | Oct 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €57.00 → €44.00 | €24.02 | n/a | 3 | Oct 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €14.00 → €14.50 | €2.91 | n/a | 2 | Sep 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $18 → $16 | $101.80 | n/a | 3 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 → $26 | $75.35 | n/a | 2 | Jul 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €4.00 → €3.50 | €1.71 | n/a | 2 | Jun 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $135 → $96 | $35.07 | n/a | 5 | May 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $39 → $35 | $46.61 | n/a | 3 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $28 | $15.23 | n/a | 1 | Apr 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $31 | $43.82 | n/a | 1 | Apr 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $76.84 | n/a | 1 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 → $55 | $24.39 | n/a | 3 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 → $7 | $13.27 | n/a | 2 | Jan 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $101 → $90 | $27.63 | n/a | 2 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $4.75 | $2.01 | n/a | 1 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $128 → $145 | $240.07 | n/a | 3 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $37 | $5.30 | n/a | 1 | Oct 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $19 | $4.18 | n/a | 3 | May 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $60 | $351.26 | n/a | 1 | Sep 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $154 | $1,007.07 | n/a | 1 | Dec 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $55.74 | n/a | 2 | Sep 23, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $10 → $11 | $4.16 | n/a | 5 | Jul 1, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2 → $1 | $0.0001 | n/a | 4 | May 28, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 | $4.52 | n/a | 1 | Apr 1, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $62 → $96 | $288.83 | n/a | 2 | Feb 13, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $4.98 | n/a | 2 | Feb 3, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $15 → $2 | $2.71 | n/a | 3 | Oct 15, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $24 | $45.49 | n/a | 3 | Mar 22, 2012 |
Corbus Pharmaceuticals Holdings
Sep 9, 2026
Reiterated: Buy
Price Target: $33
Current: $10.60
Upside: +211.47%
Belite Bio
Sep 9, 2026
Maintained: Buy
Price Target: $220 → $234
Current: $192.85
Upside: +21.34%
IDEAYA Biosciences
Sep 1, 2026
Maintained: Buy
Price Target: $50
Current: $38.84
Upside: +28.73%
Palvella Therapeutics
Aug 31, 2026
Reiterated: Buy
Price Target: $240
Current: $152.28
Upside: +57.60%
Insmed
Aug 24, 2026
Reiterated: Buy
Price Target: $192 → $195
Current: $124.89
Upside: +56.14%
Immatics
Aug 20, 2026
Reiterated: Buy
Price Target: $25
Current: $9.44
Upside: +164.83%
LeonaBio
Aug 19, 2026
Rated: Buy
Price Target: $16 → $15
Current: $8.02
Upside: +87.03%
Amylyx Pharmaceuticals
Aug 19, 2026
Reiterated: Buy
Price Target: $24 → $42
Current: $33.88
Upside: +23.97%
EyePoint
Aug 17, 2026
Maintained: Buy
Price Target: $39
Current: $4.56
Upside: +755.26%
Neumora Therapeutics
Aug 17, 2026
Reiterated: Buy
Price Target: $4
Current: $1.25
Upside: +220.00%
Aug 12, 2026
Maintained: Buy
Price Target: $306 → $316
Current: $207.82
Upside: +52.05%
Aug 12, 2026
Reiterated: Buy
Price Target: $15
Current: $13.25
Upside: +13.21%
Aug 11, 2026
Reiterated: Buy
Price Target: $30
Current: $13.93
Upside: +115.36%
Aug 11, 2026
Reiterated: Buy
Price Target: $8
Current: $4.03
Upside: +98.51%
Aug 11, 2026
Maintained: Buy
Price Target: $100
Current: $87.22
Upside: +14.65%
Aug 10, 2026
Reiterated: Buy
Price Target: $14 → $13
Current: $8.08
Upside: +60.89%
Aug 7, 2026
Maintained: Hold
Price Target: $35
Current: $35.36
Upside: -1.02%
Aug 6, 2026
Maintained: Buy
Price Target: $12
Current: $4.78
Upside: +151.05%
Aug 5, 2026
Reiterated: Buy
Price Target: $51
Current: $42.07
Upside: +21.23%
Jul 9, 2026
Maintained: Hold
Price Target: $1.5
Current: $2.47
Upside: -39.27%
Dec 9, 2025
Maintained: Buy
Price Target: $4 → $5
Current: $16.28
Upside: -69.29%
Oct 2, 2025
Downgraded: Hold
Price Target: $1,500 → $75
Current: $0.5379
Upside: +13,843.11%
Aug 26, 2025
Rated: Hold
Price Target: n/a
Current: $0.026
Upside: n/a
Dec 14, 2023
Maintained: Hold
Price Target: $1
Current: $0.82
Upside: n/a
Jun 10, 2022
Maintained: Buy
Price Target: €296.00 → €400.00
Current: €861.40
Upside: n/a
May 5, 2022
Maintained: Hold
Price Target: kr 2,270 → kr 2,754
Current: kr 2,170
Upside: n/a
May 5, 2022
Maintained: Hold
Price Target: CHF 26.50 → CHF 17.00
Current: CHF 5.08
Upside: n/a
May 5, 2022
Maintained: Hold
Price Target: €16.50
Current: €23.15
Upside: n/a
Nov 15, 2021
Maintained: Buy
Price Target: $55 → $50
Current: $108.31
Upside: n/a
Nov 9, 2021
Maintained: Hold
Price Target: $13 → $6.5
Current: $2.11
Upside: n/a
Oct 28, 2021
Maintained: Buy
Price Target: €14.00 → €6.00
Current: €2.31
Upside: n/a
Oct 5, 2021
Maintained: Sell
Price Target: €57.00 → €44.00
Current: €24.02
Upside: n/a
Sep 21, 2021
Maintained: Buy
Price Target: €14.00 → €14.50
Current: €2.91
Upside: n/a
Aug 4, 2021
Maintained: Sell
Price Target: $18 → $16
Current: $101.80
Upside: n/a
Jul 20, 2021
Maintained: Hold
Price Target: $16 → $26
Current: $75.35
Upside: n/a
Jun 29, 2021
Maintained: Hold
Price Target: €4.00 → €3.50
Current: €1.71
Upside: n/a
May 14, 2021
Maintained: Hold
Price Target: $135 → $96
Current: $35.07
Upside: n/a
May 13, 2021
Maintained: Buy
Price Target: $39 → $35
Current: $46.61
Upside: n/a
Apr 20, 2021
Initiated Coverage: Hold
Price Target: $28
Current: $15.23
Upside: n/a
Apr 19, 2021
Initiated Coverage: Hold
Price Target: $31
Current: $43.82
Upside: n/a
Mar 2, 2021
Initiated Coverage: Buy
Price Target: $20
Current: $76.84
Upside: n/a
Feb 3, 2021
Maintained: Buy
Price Target: $36 → $55
Current: $24.39
Upside: n/a
Jan 15, 2021
Maintained: Buy
Price Target: $29 → $7
Current: $13.27
Upside: n/a
Dec 21, 2020
Maintained: Sell
Price Target: $101 → $90
Current: $27.63
Upside: n/a
Nov 23, 2020
Initiated Coverage: Hold
Price Target: $4.75
Current: $2.01
Upside: n/a
Nov 11, 2020
Maintained: Sell
Price Target: $128 → $145
Current: $240.07
Upside: n/a
Oct 20, 2020
Initiated Coverage: Hold
Price Target: $37
Current: $5.30
Upside: n/a
May 11, 2020
Maintained: Buy
Price Target: $14 → $19
Current: $4.18
Upside: n/a
Sep 24, 2019
Initiated Coverage: Hold
Price Target: $60
Current: $351.26
Upside: n/a
Dec 17, 2018
Initiated Coverage: Buy
Price Target: $154
Current: $1,007.07
Upside: n/a
Sep 23, 2014
Initiated Coverage: Buy
Price Target: $16
Current: $55.74
Upside: n/a
Jul 1, 2014
Downgraded: Hold
Price Target: $10 → $11
Current: $4.16
Upside: n/a
May 28, 2014
Downgraded: Hold
Price Target: $2 → $1
Current: $0.0001
Upside: n/a
Apr 1, 2014
Downgraded: Hold
Price Target: $3
Current: $4.52
Upside: n/a
Feb 13, 2014
Reiterated: Buy
Price Target: $62 → $96
Current: $288.83
Upside: n/a
Feb 3, 2014
Reiterated: Buy
Price Target: $27
Current: $4.98
Upside: n/a
Oct 15, 2013
Downgraded: Hold
Price Target: $15 → $2
Current: $2.71
Upside: n/a
Mar 22, 2012
Reiterated: Buy
Price Target: $21 → $24
Current: $45.49
Upside: n/a